Market Cap (In USD)
2.69 Million
Revenue (In USD)
997.72 Thousand
Net Income (In USD)
-1.05 Million
Avg. Volume
6.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 10.0-23.5
- PE
- -
- EPS
- -
- Beta Value
- 0.343
- ISIN
- US4232875074
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ms. Robin L. Carmichael
- Employee Count
- -
- Website
- https://www.helixbiomedix.com
- Ipo Date
- 1999-03-25
- Details
- Helix BioMedix, Inc. operates as a specialty dermatology and consumer products skin health company in the United States. It develops and commercializes bioactive peptides, including anti-infective, anti-fungal, and anti-inflammatory peptides for the treatment of skin and wound infections, as well as for the prevention of staphylococcus aureus infections. The company also out-licenses its proprietary peptides to various entities. Helix BioMedix, Inc. was founded in 1988 and is headquartered in Bothell, Washington.
More Stocks
-
YAARI
-
688356Jenkem Technology Co., Ltd.
688356
-
ESTAR
-
5929
-
FRONTSPFrontier Springs Limited
FRONTSP
-
WRKSTheWorks.co.uk plc
WRKS
-
JOMA
-
KMSTFKadimastem Ltd
KMSTF